Can Mounjaro Make You Depressed?

Step 1: Check what Mounjaro's licensed profile actually lists

The first thing worth knowing is that depression is not among the recognised side effects of tirzepatide. The Mounjaro Summary of Product Characteristics on the eMC lists the most common adverse effects as nausea, vomiting, diarrhoea, constipation, decreased appetite, indigestion and fatigue. Mood disorders, depression and suicidal ideation do not feature in the current labelling.

That does not mean emotional symptoms are impossible. It means they have not been identified as causally linked in the clinical trial programme to date. The SURMOUNT trials, which involved thousands of adults with obesity, tracked safety outcomes extensively — and a consistent signal of depression was not one of their findings.

If you are asking whether tirzepatide can make you feel depressed, the honest answer is: not according to current evidence, but individual experiences vary, and science keeps being updated. Any new symptom you notice after starting treatment deserves attention, full stop.

Step 2: Understand why some people do report low mood

There are several plausible, non-pharmacological reasons someone might feel emotionally low during Mounjaro treatment, even if the medicine itself is not the direct cause.

Rapid weight loss is physically demanding. Reduced calorie intake can affect energy levels, sleep quality and the rhythm of daily life in ways that compound each other. Some people describe a kind of emotional flatness when their appetite drops sharply — the pleasure of eating, social meals, even the ritual of a cup of tea and a biscuit, changes in texture. That is a genuine adjustment, not a trivial one.

There is also the emotional complexity of treating a long-standing weight condition. Some people feel relief; others feel grief, anxiety about the changes, or frustration that loss is slower than expected. These are psychological responses to a significant life shift, distinct from any pharmacological effect of tirzepatide itself.

The NHS tirzepatide medicines page advises telling your doctor or pharmacist if you experience any unusual symptoms, including mood changes, so they can assess whether the medicine, your circumstances, or something else entirely is the relevant factor.

Step 3: Know when to act and who to tell

If you notice persistent low mood, loss of interest in things you normally enjoy, or any thoughts of self-harm after starting Mounjaro, do not wait until your next scheduled check-in. Contact your prescriber promptly. At nume, you can reach our team through our contact page seven days a week.

If your mood feels urgent or you are having thoughts of harming yourself, contact your GP or call 111 immediately. Mind also offers mental health information and support if you are not sure where to start.

For non-urgent mood questions, reporting anything unusual via the Yellow Card scheme helps the MHRA monitor emerging patterns across all patients. It takes a few minutes and genuinely contributes to the evidence base.

It is also worth reading about the clinical picture around Mounjaro and depression in more depth, or checking whether low mood on tirzepatide tends to resolve over time, both are questions our prescribers hear regularly.

Step 4: Weigh the broader picture of mood and GLP-1 medicines

Interestingly, some research suggests GLP-1 receptor agonists may have a neutral or even positive effect on mood in certain groups, possibly through improved metabolic health, better sleep as weight reduces, and the psychological benefit of visible progress. The evidence is not definitive, and it would be wrong to claim tirzepatide prevents or treats depression. But it is equally wrong to assume the opposite without good data.

Whether you are curious about whether Mounjaro might benefit mood or concerned about a symptom you have noticed, the answer will always depend on your personal health picture. Patients sometimes ask us about other unexpected symptoms too, including whether Mounjaro can make you bleed or whether Mounjaro can affect your vision, and that is precisely why prescribers at our clinical team review every consultation individually rather than applying a blanket approach.

Mounjaro is a prescription-only medicine for weight management and type 2 diabetes. You can read a full overview of how tirzepatide works, its evidence base and eligibility criteria on our Mounjaro information page, or explore all weight-loss treatment options if you are still deciding what suits you. When you are ready, check your eligibility with a free consultation, a real prescriber will review your answers the same day.